SK283237B6 - Pseudopolymorfné formy dihydrochloridu kyseliny 2-[2-[4-[bis(4-fluórfenyl)metyl]-1-piperazinyl]etoxy]octovej, spôsob ich prípravy a farmaceutické kompozície s ich obsahom - Google Patents

Pseudopolymorfné formy dihydrochloridu kyseliny 2-[2-[4-[bis(4-fluórfenyl)metyl]-1-piperazinyl]etoxy]octovej, spôsob ich prípravy a farmaceutické kompozície s ich obsahom Download PDF

Info

Publication number
SK283237B6
SK283237B6 SK594-2000A SK5942000A SK283237B6 SK 283237 B6 SK283237 B6 SK 283237B6 SK 5942000 A SK5942000 A SK 5942000A SK 283237 B6 SK283237 B6 SK 283237B6
Authority
SK
Slovakia
Prior art keywords
methyl
piperazinyl
fluorophenyl
bis
ethoxy
Prior art date
Application number
SK594-2000A
Other languages
English (en)
Slovak (sk)
Other versions
SK5942000A3 (en
Inventor
Monique Berwaer
Guy Bodson
Michel Deleers
Charles Dogimont
Domenico Fanara
Jacques Timmermans
Original Assignee
Ucb S. A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ucb S. A. filed Critical Ucb S. A.
Publication of SK5942000A3 publication Critical patent/SK5942000A3/sk
Publication of SK283237B6 publication Critical patent/SK283237B6/sk

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C07D295/084—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/088—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/14—Decongestants or antiallergics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/06—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by halogen atoms or nitro radicals
    • C07D295/073—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by halogen atoms or nitro radicals with the ring nitrogen atoms and the substituents separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Neurology (AREA)
  • Pain & Pain Management (AREA)
  • Dermatology (AREA)
  • Immunology (AREA)
  • Neurosurgery (AREA)
  • Ophthalmology & Optometry (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Biomedical Technology (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
SK594-2000A 1997-11-26 1998-11-26 Pseudopolymorfné formy dihydrochloridu kyseliny 2-[2-[4-[bis(4-fluórfenyl)metyl]-1-piperazinyl]etoxy]octovej, spôsob ich prípravy a farmaceutické kompozície s ich obsahom SK283237B6 (sk)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP97870193A EP0919550A1 (en) 1997-11-26 1997-11-26 Pseudopolymorphic forms of 2-2-4-bis(4-fluorophenyl)methyl-1-piperazinyl-ethoxy acetic acid dihydrochloride
PCT/BE1998/000184 WO1999028310A1 (en) 1997-11-26 1998-11-26 Pseudopolymorphic forms of 2-[2-[4-[bis (4-fluorophenyl) methyl]-1-piperazinyl] ethoxy]acetic acid dihydrochloride

Publications (2)

Publication Number Publication Date
SK5942000A3 SK5942000A3 (en) 2000-10-09
SK283237B6 true SK283237B6 (sk) 2003-04-01

Family

ID=8231072

Family Applications (1)

Application Number Title Priority Date Filing Date
SK594-2000A SK283237B6 (sk) 1997-11-26 1998-11-26 Pseudopolymorfné formy dihydrochloridu kyseliny 2-[2-[4-[bis(4-fluórfenyl)metyl]-1-piperazinyl]etoxy]octovej, spôsob ich prípravy a farmaceutické kompozície s ich obsahom

Country Status (39)

Country Link
US (2) US6262057B1 (no)
EP (2) EP0919550A1 (no)
JP (2) JP3996348B2 (no)
KR (1) KR100557711B1 (no)
CN (1) CN100406448C (no)
AR (1) AR017676A1 (no)
AT (1) ATE203237T1 (no)
AU (1) AU735819B2 (no)
BG (1) BG64155B1 (no)
BR (1) BR9815405A (no)
CA (1) CA2310318C (no)
CO (1) CO4980892A1 (no)
CZ (1) CZ295972B6 (no)
DE (1) DE69801163T2 (no)
DK (1) DK1034171T3 (no)
EG (1) EG23776A (no)
ES (1) ES2161552T3 (no)
GC (1) GC0000094A (no)
GR (1) GR3036702T3 (no)
HU (1) HUP0100343A3 (no)
ID (1) ID24964A (no)
IL (1) IL135544A (no)
MA (1) MA26569A1 (no)
MY (1) MY119653A (no)
NO (1) NO314692B1 (no)
NZ (1) NZ504461A (no)
PE (1) PE134899A1 (no)
PL (1) PL190871B1 (no)
PT (1) PT1034171E (no)
RS (1) RS49904B (no)
RU (1) RU2182575C2 (no)
SI (1) SI20325A (no)
SK (1) SK283237B6 (no)
TN (1) TNSN98214A1 (no)
TR (1) TR200001505T2 (no)
TW (1) TWI225053B (no)
UA (1) UA54568C2 (no)
WO (1) WO1999028310A1 (no)
ZA (1) ZA9810780B (no)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2002221854A1 (en) * 2000-12-15 2002-06-24 U C B, S.A. Use of cetirizine or efletirizine for preventing urticaria
EP1414460A1 (en) * 2001-07-26 2004-05-06 Ucb, S.A. Process for the preparation of 2-(2-(4-(bis(4-fluorophenyl)methyl)-piperazin-1-yl)ethoxy)acetic acid derivatives or corresponding salt forms thereof and intermediates therefor
US20050181032A1 (en) * 2002-06-25 2005-08-18 Acrux Dds Pty Ltd. Metastable pharmaceutical compositions
JP5160018B2 (ja) 2002-06-25 2013-03-13 アクルックス・ディ・ディ・エス・プロプライエタリー・リミテッド 非晶質医薬組成物を用いる経皮送達速度調節
WO2004105760A1 (en) * 2003-05-28 2004-12-09 Ucb Farchim, S.A. Use of efletirizine for treating persistent allergic rhinitis
WO2006050909A1 (en) * 2004-11-10 2006-05-18 Ucb Farchim Sa Novel forms of efletirizine dihydrochloride, processes for making them and pharmaceutical compositions including them
WO2008155777A2 (en) * 2007-06-18 2008-12-24 Cadila Healthcare Limited Process for preparing efletrizine
KR101006760B1 (ko) * 2008-07-17 2011-01-11 주식회사 진영테크 모터 순간 정전 복원 장치

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH505116A (it) * 1966-11-21 1971-03-31 Crc Ricerca Chim Metodo per l'ottenimento di derivati della piperazina
SE409706B (sv) 1976-05-21 1979-09-03 Astra Pharma Prod Forfarande for framstellning av n,n-dimetyl-3-(4-bromfenyl)-3-3(3-pyridyl)-allylamin dihydroklorid monohydrat
ZA82752B (en) * 1981-02-06 1982-12-29 Ucb Sa 2-(4-(diphenylmethyl)-1-piperazinyl)-acetic acids and their amides
NO155805C (no) 1981-02-06 1987-06-10 Ucb Sa Analogifremgangsmaate for fremstilling av terapeutisk virksomme 2-(4-(difenylmethyl)-1-piperazinyl)-eddiksyrer og deres amider og ikke-toksiske salter.
GB8827390D0 (en) * 1988-11-23 1988-12-29 Ucb Sa Process for preparation of 2-(2-(4-((4-chlorophenyl)phenylmethyl)-1-pipera-zinyl)ethoxy)-acetic acid & its dihydrochloride
GB8827391D0 (en) * 1988-11-23 1988-12-29 Ucb Sa Process for preparation of 2-(2-(4-((4-chlorophenyl)phenylmethyl)-1-pipera-zinyl)ethoxy)-acetic acid & its dihydrochloride
US5968551A (en) * 1991-12-24 1999-10-19 Purdue Pharma L.P. Orally administrable opioid formulations having extended duration of effect
TW401300B (en) * 1992-12-25 2000-08-11 Senju Pharma Co Antiallergic composition for ophthalmic or nasal use
US5625358A (en) * 1993-09-13 1997-04-29 Analog Devices, Inc. Digital phase-locked loop utilizing a high order sigma-delta modulator
BE1010094A3 (fr) * 1996-04-10 1997-12-02 Ucb Sa Nouveaux [2-(1-piperazinyl)ethoxy] methyle substitues.
BE1010095A3 (fr) * 1996-04-10 1997-12-02 Ucb Sa Procede de preparation de l'acide 2-[2-[4-[(4-chlorophenyl)phenylmethyl]-1-piperazinyl] ethoxy]-acetique et de ses sels.

Also Published As

Publication number Publication date
EP1034171A1 (en) 2000-09-13
EP1034171B1 (en) 2001-07-18
BG104424A (en) 2001-01-31
NO314692B1 (no) 2003-05-05
IL135544A0 (en) 2001-05-20
KR20010032420A (ko) 2001-04-16
SI20325A (sl) 2001-02-28
GC0000094A (en) 2005-06-29
NZ504461A (en) 2001-06-29
NO20002631L (no) 2000-05-23
AU735819B2 (en) 2001-07-19
MA26569A1 (fr) 2004-12-20
EP0919550A1 (en) 1999-06-02
NO20002631D0 (no) 2000-05-23
PT1034171E (pt) 2001-11-30
RS49904B (sr) 2008-08-07
RU2182575C2 (ru) 2002-05-20
DE69801163T2 (de) 2002-03-28
ES2161552T3 (es) 2001-12-01
JP2001524548A (ja) 2001-12-04
CA2310318C (en) 2003-10-21
ZA9810780B (en) 1999-05-31
DK1034171T3 (da) 2001-11-05
PE134899A1 (es) 2000-01-11
AR017676A1 (es) 2001-09-12
PL340724A1 (en) 2001-02-26
SK5942000A3 (en) 2000-10-09
UA54568C2 (uk) 2003-03-17
JP2007224042A (ja) 2007-09-06
HUP0100343A3 (en) 2001-09-28
TWI225053B (en) 2004-12-11
CN1279676A (zh) 2001-01-10
PL190871B1 (pl) 2006-02-28
GR3036702T3 (en) 2001-12-31
CO4980892A1 (es) 2000-11-27
ID24964A (id) 2000-08-31
US6262057B1 (en) 2001-07-17
CZ295972B6 (cs) 2005-12-14
KR100557711B1 (ko) 2006-03-07
US6335331B2 (en) 2002-01-01
DE69801163D1 (en) 2001-08-23
TNSN98214A1 (fr) 2005-03-15
JP3996348B2 (ja) 2007-10-24
EG23776A (en) 2007-08-08
CA2310318A1 (en) 1999-06-10
TR200001505T2 (tr) 2000-09-21
IL135544A (en) 2004-02-08
MY119653A (en) 2005-06-30
CZ20001787A3 (cs) 2000-09-13
HUP0100343A2 (hu) 2001-07-30
BG64155B1 (bg) 2004-02-27
YU31600A (sh) 2002-03-18
CN100406448C (zh) 2008-07-30
BR9815405A (pt) 2000-10-10
AU1327799A (en) 1999-06-16
US20010021712A1 (en) 2001-09-13
WO1999028310A1 (en) 1999-06-10
ATE203237T1 (de) 2001-08-15

Similar Documents

Publication Publication Date Title
EP2897943B1 (en) Crystalline form of vortioxetine hydrobromide
US7439358B2 (en) Specific salt, anhydrous and crystalline form of a dihydropteridione derivative
EP1709053B1 (en) Stable salts of olanzapine
EP3022209B1 (en) Dolutegravir potassium salt
EP1853232B1 (en) Stable crystalline form of bifeprunox mesylate, dosage forms thereof adn methods for using them
JP2007224042A (ja) ２−〔２−〔４−〔ビス（４−フルオロフェニル）メチル〕−１−ピペラジニル〕エトキシ〕酢酸ジヒドロクロリドの偽多形
WO2015176591A1 (zh) 贝曲西班盐及其制备方法和用途
CZ20022858A3 (cs) Mesylát a polymorfy 4-amino-6,7-dimethoxy-2-(5-methansulfonamido-1,2,3,4-tetrahydroisochinol-2-yl)-5-(2-pyridyl)chinazolinu
EP3656767A1 (en) Beraprost-314d monohydrate crystals and methods for preparation thereof
EA020944B1 (ru) Кристаллическая форма i соли розувастатина цинка
MXPA00004826A (en) Pseudopolymorphic forms of 2-[2-[4-[bis (4-fluorophenyl) methyl]-1-piperazinyl]ethoxy]acetic acid dihydrochloride
NZ743660A (en) Crystalline forms of hydrochloride salts of thienopyrimidine compound
EP2408748A2 (en) Aripiprazole salts